1 year return (CAGR)
252.51%
Faeth Therapeutics, Inc. Exchange (NASDAQ, USD)
FTH
31.55
-1.85 (-5.54%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
23.28%
5 year return (CAGR)
-31.81%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
815.27M
Price/Sales
-
Ent value
804.71M
Price/Book
4.71
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 32.71 |
| Daily high | 33.95 |
| Daily low | 31.37 |
| Daily Volume | 435K |
| All-time high | 455.00 |
| 1y analyst estimate | 54.64 |
| Beta | -0.31 |
| EPS (TTM) | -34.65 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| FTH | S&P500 | |
| Current price drop from All-time high | -93.07% | -1.29% |
| Highest price drop | -98.73% | -56.47% |
| Date of highest drop | 4 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -87.91% | -10.68% |
| Avg time to new high | 472 days | 12 days |
| Max time to new high | 1413 days | 1805 days |
News
